Sleep EEG effects of anti-gluco- and anti-mineralocorticoids in old-aged men: 
Pilot study

Demiralay, Cueneyt; Agorastos, Agorastos; Steiger, Axel; Wiedemann, Klaus

doi:10.1111/pcn.12142

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Sleep EEG effects of anti-gluco- and anti-mineralocorticoids in old-aged men: Pilot study

MPS-Authors

/persons/resource/persons80541

Steiger, Axel
Dept. Clinical Research, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons141838

Wiedemann, Klaus
external;
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Demiralay, C., Agorastos, A., Steiger, A., & Wiedemann, K. (2014). Sleep EEG effects of anti-gluco- and anti-mineralocorticoids in old-aged men: Pilot study. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 68(5), 383-387. doi:10.1111/pcn.12142.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0024-CF6A-7

Abstract

Aim Age-related sleep changes have been associated with altered hypothalamic-pituitary-adrenal axis reactivity and impaired feedback inhibition at the glucocorticoid (GR) and mineralocorticoid (MR) receptor level. To further investigate the specific role of this binary receptor system in the elderly, sleep electroencephalogram (EEG) effects of the MR antagonist spironolactone and GR antagonist mifepristone in old-aged men were compared in this pilot study. Methods Old-aged healthy men (n=6, 65-91 years) were treated on three occasions in a single-blinded design in random order with mifepristone, spironolactone and placebo, respectively, and nocturnal sleep EEG was recorded. Results Mifepristone led to increased wake time, decreased stage 2 and rapid eye movement (REM) sleep and prolonged REM sleep latency in the first half of the night, whereas spironolactone had no considerable effects on sleep EEG. Conclusion GR antagonism can potentiate age-related sleep pattern alterations and further support the role of impaired GR signaling in age-related changes in sleep architecture.